This webinar addresses the following topics pertaining to genetics and genomics for ovarian cancer:
- The latest research on genetics and genomics for ovarian cancer
- How does your genetics affect treatment?
- The importance and role of genomics as it pertains to treatment
- PARP Inhibitors
- The importance of genetics for family members
Dr. Melissa Frey, MD, Assistant Professor of Obstetrics and Gynecology in the division of gynecologic oncology at Weill Cornell Medicine.
Dr. Frey specializes in all aspects of gynecologic oncology. Her research focuses on genetics and genomics in gynecologic cancer. She has presented her research at national and international meetings and has more than 50 publications in peer-reviewed scientific journals. Much of Dr. Frey’s research has focused on genetic syndromes that predispose to gynecologic cancer including hereditary breast and ovarian cancer (BRCA1/BRCA2) and Lynch syndrome.
Dr. Frey graduated magna cum laude from Duke University and earned her medical degree from Weill Cornell Medical College, graduating with honors in research. She completed her residency in Obstetrics and Gynecology at Weill Cornell Medicine / NewYork-Presbyterian. She subsequently completed her fellowship in gynecologic oncology at New York University Langone Medical Center. Dr. Frey has received numerous awards for her clinical excellence, surgical expertise and medical research, as well as many teaching awards.